# Azithromycin a Treatment for Pulmonary Sarcoidosis

> **NCT04020380** · PHASE2 · COMPLETED · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 21 (actual)

## Conditions studied

- Sarcoidosis, Pulmonary

## Interventions

- **DRUG:** Azithromycin 250Mg Capsule

## Key facts

- **NCT ID:** NCT04020380
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-06
- **Primary completion:** 2020-06-20
- **Final completion:** 2020-06-20
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2020-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04020380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04020380, "Azithromycin a Treatment for Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04020380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*